A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Clinical trial NCT05100056 · RECRUITING

Trial details

NCT number: NCT05100056
Sponsor: Takeda
Status: RECRUITING
Study type: OBSERVATIONAL

Hodgkin Lymphoma

Start date: 2022-03-08
Primary completion: 2027-01-13
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.